Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines.
Ontology highlight
ABSTRACT: Primary mitochondrial disease describes a diverse group of neuro-metabolic disorders characterised by impaired oxidative phosphorylation. Diagnosis is challenging; >350 genes, both nuclear and mitochondrial DNA (mtDNA) encoded, are known to cause mitochondrial disease, leading to all possible inheritance patterns and further complicated by heteroplasmy of the multicopy mitochondrial genome. Technological advances, particularly next-generation sequencing, have driven a shift in diagnostic practice from 'biopsy first' to genome-wide analyses of blood and/or urine DNA. This has led to the need for a reference framework for laboratories involved in mitochondrial genetic testing to facilitate a consistent high-quality service. In the United Kingdom, consensus guidelines have been prepared by a
SUBMITTER: Mavraki E
PROVIDER: S-EPMC9905091 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA